Literature DB >> 4790616

Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

S Eykyn, C Jenkins, A King, I Phillips.   

Abstract

The in vitro antibacterial activity of cefamandole, a new cephalosporin antibiotic, was compared with that of cephaloridine, cephalothin, and cephalexin against 1,213 strains of gram-positive and gram-negative bacteria recently isolated from clinical sources. The decreasing order of activity of the four agents against gram-positive cocci was cephaloridine, cephalothin, cefamandole, and cephalexin. However, cefamandole was the most active of the four against Haemophilus species and gram-negative bacilli susceptible to cephalosporins. It was also active against many strains resistant to the other cephalosporins, such as Enterobacter species and indole-positive Proteus species, but there was a marked inoculum effect with all of these organisms, and minimal bactericidal concentrations were usually considerably higher than minimal inhibitory concentrations. Cefamandole, like other cephalosporins, had no useful activity against Pseudomonas species.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790616      PMCID: PMC444475          DOI: 10.1128/AAC.3.6.657

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Outbreak of hospital infection caused by contaminated autoclaved fluids.

Authors:  I Phillips; S Eykyn; M Laker
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

2.  Use and control of cephalosporins.

Authors:  S Eykyn
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

  2 in total
  46 in total

1.  In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.

Authors:  G D Overturf; R L Ressler; P B Marengo; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Clinical pharmacology of cefamandole as compared with cephalothin.

Authors:  I W Fong; E D Ralph; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Penetration of cefamandole into spinal fluid.

Authors:  E A Steinberg; G D Overturf; L J Baraff; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

5.  Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.

Authors:  M J Ahern; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.

Authors:  R T Jackson; F E Thomas; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

8.  Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.

Authors:  R P Mouton; G P Bongaerts; M van Gestel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  In vitro evaluation of cefoxitin and cefamandole.

Authors:  H G Adams; G A Stilwell; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.